MedPath

The Serotonergic Transmitter System in Dementia and Affective Disorders

Conditions
Mood Disorders
Alzheimer Disease
Registration Number
NCT00192998
Lead Sponsor
Rigshospitalet, Denmark
Brief Summary

The aim of this project is to examine the serotonergic transmitter system using functional imaging of the brain (positron emission tomography \[PET\]) to gain knowledge about early pathophysiological changes in Alzheimer's dementia and mood disorders.

Detailed Description

Not available

Recruitment & Eligibility

Status
UNKNOWN
Sex
All
Target Recruitment
100
Inclusion Criteria
  • Moderate to severe Alzheimer's disease
  • Individuals genetically predisposed to affective disorder
  • Healthy gender and age matched controls
Exclusion Criteria
  • Contraindications to magnetic resonance imaging (MRI)
  • Use of psychoactive drugs
  • Past or present affective disorder
  • Other systemic diseases that may affect brain function

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Neurobiological Research Unit

🇩🇰

Copenhagen, Denmark

© Copyright 2025. All Rights Reserved by MedPath